首页 > 最新文献

Infection Control and Hospital Epidemiology最新文献

英文 中文
Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia. 用于评估急性白血病患者腹泻的多重胃肠道 PCR 图谱。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-08 DOI: 10.1017/ice.2024.182
Clyde D Ford, Bert K Lopansri, Bradley D Hunter, Jacob Wilkes, Julie Asch, Daanish Hoda

Objective: To better delineate multiplexed gastrointestinal polymerase chain reaction (PCR) panel (MGPP) diagnostic and therapeutic stewardship for patients undergoing treatment for acute leukemia including indications and benefits of testing, optimal timing, and interpretation of results.

Study design: We retrieved all MGPP ordered on 662 consecutive patients admitted with newly diagnosed acute leukemia between June 2015 and May 2024.

Setting: Regional referral center for acute leukemia.

Results: Fifty-one (17%) of 305 MGPP obtained on the 198 patients who underwent testing identified at least one and 4 (1%) more than one diarrheagenic pathogen. The probability of a positive result was greater if obtained as an outpatient [20/52(38%)], but was not related to type of leukemia, sex, or age. Among the positive results, the pathogens identified included Clostridioides difficile (78% of tests), norovirus (16%), diarrheagenic Escherichia coli (6%), adenovirus 40/41 (4%), and Giardia lamblia (4%). The results of 30 of the 305 tests resulted in a change in treatment (28 C. difficile, 2 G. lamblia). For the MGPP C. difficile results with an accompanying toxin determination, this included treatment following 16/19 tests with a positive toxin result and 11/19 with a negative. Actionable results other than C. difficile were rarely seen in the inpatient population.

Conclusions: MGPP testing is most useful when administered as an outpatient and of little benefit for inpatients with hospital-onset diarrhea. Since MGPP is sensitive and does not distinguish between colonization and causes of diarrhea, caution is needed in interpretation of results, especially for toxin-negative C. difficile.

目标:研究设计:我们检索了2015年6月至2024年5月期间连续收治的662名新确诊急性白血病患者的所有MGPP订单:研究设计:我们检索了 2015 年 6 月至 2024 年 5 月间新确诊急性白血病的 662 名连续入院患者的所有 MGPP 订单:地区急性白血病转诊中心:在接受检测的 198 名患者的 305 份 MGPP 中,有 51 份(17%)发现了至少一种腹泻病原体,4 份(1%)发现了一种以上的腹泻病原体。如果是门诊患者,阳性结果的概率更高[20/52(38%)],但与白血病类型、性别或年龄无关。在阳性结果中,确定的病原体包括艰难梭菌(78%)、诺如病毒(16%)、致泻性大肠杆菌(6%)、腺病毒 40/41(4%)和贾第鞭毛虫(4%)。在 305 项检测中,有 30 项检测的结果导致治疗方法的改变(艰难梭菌 28 项,蓝氏贾第鞭毛虫 2 项)。在 MGPP 艰难梭菌检测结果中,毒素检测结果呈阳性的有 16/19 例,呈阴性的有 11/19 例。除艰难梭菌外,住院病人中很少出现其他可采取行动的结果:结论:MGPP 检测在门诊患者中最有用,对住院腹泻患者的益处不大。由于 MGPP 比较敏感,而且不能区分定植和腹泻的原因,因此在解释结果时需要谨慎,尤其是对毒素阴性的艰难梭菌。
{"title":"Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia.","authors":"Clyde D Ford, Bert K Lopansri, Bradley D Hunter, Jacob Wilkes, Julie Asch, Daanish Hoda","doi":"10.1017/ice.2024.182","DOIUrl":"https://doi.org/10.1017/ice.2024.182","url":null,"abstract":"<p><strong>Objective: </strong>To better delineate multiplexed gastrointestinal polymerase chain reaction (PCR) panel (MGPP) diagnostic and therapeutic stewardship for patients undergoing treatment for acute leukemia including indications and benefits of testing, optimal timing, and interpretation of results.</p><p><strong>Study design: </strong>We retrieved all MGPP ordered on 662 consecutive patients admitted with newly diagnosed acute leukemia between June 2015 and May 2024.</p><p><strong>Setting: </strong>Regional referral center for acute leukemia.</p><p><strong>Results: </strong>Fifty-one (17%) of 305 MGPP obtained on the 198 patients who underwent testing identified at least one and 4 (1%) more than one diarrheagenic pathogen. The probability of a positive result was greater if obtained as an outpatient [20/52(38%)], but was not related to type of leukemia, sex, or age. Among the positive results, the pathogens identified included <i>Clostridioides difficile</i> (78% of tests), norovirus (16%), diarrheagenic <i>Escherichia coli</i> (6%), adenovirus 40/41 (4%), and <i>Giardia lamblia</i> (4%). The results of 30 of the 305 tests resulted in a change in treatment (28 <i>C. difficile</i>, 2 <i>G. lamblia</i>). For the MGPP <i>C. difficile</i> results with an accompanying toxin determination, this included treatment following 16/19 tests with a positive toxin result and 11/19 with a negative. Actionable results other than <i>C. difficile</i> were rarely seen in the inpatient population.</p><p><strong>Conclusions: </strong>MGPP testing is most useful when administered as an outpatient and of little benefit for inpatients with hospital-onset diarrhea. Since MGPP is sensitive and does not distinguish between colonization and causes of diarrhea, caution is needed in interpretation of results, especially for toxin-negative <i>C. difficile</i>.</p>","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating an industrial hygienist into the infection prevention and control program. 将工业卫生学家纳入感染预防和控制计划。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-07 DOI: 10.1017/ice.2024.123
Angelique Dains, Spencer Baker, Takaaki Kobayashi, Stephanie Holley, Daniel Diekema, Karen Brust
{"title":"Integrating an industrial hygienist into the infection prevention and control program.","authors":"Angelique Dains, Spencer Baker, Takaaki Kobayashi, Stephanie Holley, Daniel Diekema, Karen Brust","doi":"10.1017/ice.2024.123","DOIUrl":"10.1017/ice.2024.123","url":null,"abstract":"","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial-resistant central line-associated bloodstream infections in adult intensive care units: findings from an Australian surveillance network, 2011-2022. 成人重症监护病房中耐药中心管路相关血流感染:2011-2022 年澳大利亚监测网络的发现。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-07 DOI: 10.1017/ice.2024.132
Lyn-Li Lim, Kang Wei Esther Lim, Michael J Malloy, Ann Bull, Judith Brett, Leon J Worth

Objective: We aimed to describe the incidence, pathogens, and antimicrobial susceptibility of central line-associated bloodstream infections (CLABSI) in adult intensive care units (ICU).

Design: State surveillance data from 2011 to 2022 were analyzed to identify patient and device days and CLABSI events. Pathogen data were analyzed to determine the most common organisms and patterns of antimicrobial resistance grouped into 3-year time epochs.

Setting: Adult ICU in Victoria, Australia.

Participants: Healthcare organizations participating in CLABSI state surveillance.

Results: 608 events were reported over 751,350 device days. Overall, CLABSI incidence was 0.81 per 1,000 central-line days, with a 49.3% rate reduction from 2011 to 2022 (1.39 to 0.70 per 1,000 central-line days). Overall device utilization ratio was 0.57, with a 15.4% reduction from 2011 to 2022 (0.67 vs 0.56). Of 690 pathogens, the most common by rank order were coagulase-negative Staphylococci (CNS), Candida species, Staphylococcus aureus, and Enterococcus faecalis. The proportion of CNS-causing events increased by 69.0% from 2011 to 2022; this trend was not observed for other organisms. For every increase in epoch, a 33% decrease in methicillin-resistant S. aureus (MRSA), 4% increase in vancomycin-resistant Enterococcus faecium, and 12% increase in ceftriaxone-resistant Escherichia coli pathogens were observed.

Conclusions: We demonstrate a decreasing incidence of CLABSI in Victorian adult ICU and an increasing burden of infections due to CNS. No significant time trend increases in antimicrobial-resistant organisms, including MRSA, vancomycin-resistant E. faecium, and ceftriaxone-resistant E. coli were observed. These findings are relevant for identifying priorities for CLABSI prevention in Victorian adult ICU.

目的我们旨在描述成人重症监护病房(ICU)中中心管路相关血流感染(CLABSI)的发病率、病原体和抗菌药物敏感性:设计:对 2011 年至 2022 年的州监控数据进行分析,以确定患者和设备感染天数以及 CLABSI 事件。对病原体数据进行了分析,以确定最常见的病原体和抗菌药耐药性模式,并按 3 年时间段进行分组:环境:澳大利亚维多利亚州成人重症监护室:参与 CLABSI 状态监测的医疗机构:结果:在 751,350 个设备日内报告了 608 起事件。总体而言,CLABSI 发生率为每 1000 个中心管路日 0.81 例,从 2011 年到 2022 年下降了 49.3%(每 1000 个中心管路日从 1.39 例降至 0.70 例)。总体设备使用率为 0.57,从 2011 年到 2022 年降低了 15.4%(0.67 vs 0.56)。在 690 种病原体中,最常见的病原体依次为凝固酶阴性葡萄球菌 (CNS)、念珠菌、金黄色葡萄球菌和粪肠球菌。从 2011 年到 2022 年,由 CNS 引起的事件比例增加了 69.0%;而其他微生物则没有出现这种趋势。随着时间的推移,耐甲氧西林金黄色葡萄球菌(MRSA)减少了33%,耐万古霉素粪肠球菌增加了4%,耐头孢曲松大肠埃希菌病原体增加了12%:我们发现维多利亚州成人重症监护病房 CLABSI 的发生率在下降,而中枢神经系统感染的负担在增加。抗菌生物(包括 MRSA、耐万古霉素的粪大肠杆菌和耐头孢曲松的大肠杆菌)的增加没有明显的时间趋势。这些研究结果有助于确定维多利亚州成人重症监护病房预防 CLABSI 的重点。
{"title":"Antimicrobial-resistant central line-associated bloodstream infections in adult intensive care units: findings from an Australian surveillance network, 2011-2022.","authors":"Lyn-Li Lim, Kang Wei Esther Lim, Michael J Malloy, Ann Bull, Judith Brett, Leon J Worth","doi":"10.1017/ice.2024.132","DOIUrl":"10.1017/ice.2024.132","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to describe the incidence, pathogens, and antimicrobial susceptibility of central line-associated bloodstream infections (CLABSI) in adult intensive care units (ICU).</p><p><strong>Design: </strong>State surveillance data from 2011 to 2022 were analyzed to identify patient and device days and CLABSI events. Pathogen data were analyzed to determine the most common organisms and patterns of antimicrobial resistance grouped into 3-year time epochs.</p><p><strong>Setting: </strong>Adult ICU in Victoria, Australia.</p><p><strong>Participants: </strong>Healthcare organizations participating in CLABSI state surveillance.</p><p><strong>Results: </strong>608 events were reported over 751,350 device days. Overall, CLABSI incidence was 0.81 per 1,000 central-line days, with a 49.3% rate reduction from 2011 to 2022 (1.39 to 0.70 per 1,000 central-line days). Overall device utilization ratio was 0.57, with a 15.4% reduction from 2011 to 2022 (0.67 vs 0.56). Of 690 pathogens, the most common by rank order were coagulase-negative Staphylococci (CNS), <i>Candida</i> species, <i>Staphylococcus aureus</i>, and <i>Enterococcus faecalis</i>. The proportion of CNS-causing events increased by 69.0% from 2011 to 2022; this trend was not observed for other organisms. For every increase in epoch, a 33% decrease in methicillin-resistant <i>S. aureus</i> (MRSA), 4% increase in vancomycin-resistant <i>Enterococcus faecium</i>, and 12% increase in ceftriaxone-resistant <i>Escherichia coli</i> pathogens were observed.</p><p><strong>Conclusions: </strong>We demonstrate a decreasing incidence of CLABSI in Victorian adult ICU and an increasing burden of infections due to CNS. No significant time trend increases in antimicrobial-resistant organisms, including MRSA, vancomycin-resistant <i>E. faecium</i>, and ceftriaxone-resistant <i>E. coli</i> were observed. These findings are relevant for identifying priorities for CLABSI prevention in Victorian adult ICU.</p>","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sustainability of a customized electronic duplicate order alert for microbiology tests: assessment of alert fatigue 12 to 36 months after implementation. 微生物检验定制电子重复订单警报的可持续性:实施 12 至 36 个月后的警报疲劳评估。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-07 DOI: 10.1017/ice.2024.183
Maryza Graham, Victoria Hornidge, Gillian Yap, Allen Cheng, Anjali Dhulia, Beena Kumar
{"title":"Sustainability of a customized electronic duplicate order alert for microbiology tests: assessment of alert fatigue 12 to 36 months after implementation.","authors":"Maryza Graham, Victoria Hornidge, Gillian Yap, Allen Cheng, Anjali Dhulia, Beena Kumar","doi":"10.1017/ice.2024.183","DOIUrl":"10.1017/ice.2024.183","url":null,"abstract":"","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pilot intervention trial to reduce the use of post-procedural antimicrobials after common endourologic surgeries. 减少常见腔内手术后抗菌药物使用的试点干预试验。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-07 DOI: 10.1017/ice.2024.172
Daniel J Livorsi, Vignesh T Packiam, Qianyi Shi, Steven Y Alberding, Knute D Carter, James A Brown, James B Mason, Jeffrey P Weiss, Ryan L Steinberg

Objective: Post-procedural antimicrobial prophylaxis is not recommended by professional guidelines but is commonly prescribed. We sought to reduce use of post-procedural antimicrobials after common endoscopic urologic procedures.

Design: A before-after, quasi-experimental trial with a baseline (July 2020-June 2022), an implementation (July 2022), and an intervention period (August 2022-July 2023).

Setting: Three participating medical centers.

Intervention: We assessed the effect of a bundled intervention on excess post-procedural antimicrobial use (ie, antimicrobial use on post-procedural day 1) after three types of endoscopic urologic procedures: ureteroscopy and transurethral resection of bladder tumor or prostate. The intervention consisted of education, local champion(s), and audit-and-feedback of data on the frequency of post-procedural antimicrobial-prescribing.

Results: 1,272 procedures were performed across all 3 sites at baseline compared to 525 during the intervention period; 644 (50.6%) patients received excess post-procedural antimicrobials during the baseline period compared to 216 (41.1%) during the intervention period. There was no change in the use of post-procedural antimicrobials at sites 1 and 2 between the baseline and intervention periods. At site 3, the odds of prescribing a post-procedural antimicrobial significantly decreased during the intervention period relative to the baseline time trend (0.09; 95% CI 0.02-0.45). There was no significant increase in post-procedural unplanned visits at any of the sites.

Conclusions: Implementation of a bundled intervention was associated with reduced post-procedural antimicrobial use at one of three sites, with no increase in complications. These findings demonstrate both the safety and challenge of guideline implementation for optimal perioperative antimicrobial prophylaxis.This trial was registered on clinicaltrials.gov, NCT04196777.

目的:专业指南并未推荐术后抗菌药预防,但处方却很普遍。我们试图减少常见内窥镜泌尿外科手术后抗菌药物的使用:设计:一项前后对比的准实验性试验,基线期(2020 年 7 月至 2022 年 6 月)、实施期(2022 年 7 月)和干预期(2022 年 8 月至 2023 年 7 月):三个参与试验的医疗中心:我们评估了捆绑干预对三种内窥镜泌尿外科手术(输尿管镜检查和经尿道膀胱肿瘤或前列腺切除术)术后抗菌药物超量使用(即术后第 1 天的抗菌药物使用)的影响。干预措施包括教育、地方冠军以及术后抗菌药物处方频率数据的审核和反馈:基线期间,3 个地点共进行了 1,272 例手术,而干预期间则为 525 例;基线期间有 644 例(50.6%)患者术后过量使用抗菌药物,而干预期间则为 216 例(41.1%)。在基线期和干预期之间,1 号和 2 号研究点的术后抗菌药物使用率没有变化。与基线时间趋势相比(0.09;95% CI 0.02-0.45),第 3 治疗点在干预期间开出术后抗菌药处方的几率明显下降。结论:捆绑干预措施的实施与术后非计划就诊率相关:结论:捆绑干预措施的实施与三个医疗点中一个医疗点术后抗菌药物使用量的减少有关,但并发症并未增加。这些研究结果表明,实施围手术期最佳抗菌药物预防指南既安全又具有挑战性。该试验已在 clinicaltrials.gov 上注册,编号为 NCT04196777。
{"title":"A pilot intervention trial to reduce the use of post-procedural antimicrobials after common endourologic surgeries.","authors":"Daniel J Livorsi, Vignesh T Packiam, Qianyi Shi, Steven Y Alberding, Knute D Carter, James A Brown, James B Mason, Jeffrey P Weiss, Ryan L Steinberg","doi":"10.1017/ice.2024.172","DOIUrl":"10.1017/ice.2024.172","url":null,"abstract":"<p><strong>Objective: </strong>Post-procedural antimicrobial prophylaxis is not recommended by professional guidelines but is commonly prescribed. We sought to reduce use of post-procedural antimicrobials after common endoscopic urologic procedures.</p><p><strong>Design: </strong>A before-after, quasi-experimental trial with a baseline (July 2020-June 2022), an implementation (July 2022), and an intervention period (August 2022-July 2023).</p><p><strong>Setting: </strong>Three participating medical centers.</p><p><strong>Intervention: </strong>We assessed the effect of a bundled intervention on excess post-procedural antimicrobial use (<i>ie</i>, antimicrobial use on post-procedural day 1) after three types of endoscopic urologic procedures: ureteroscopy and transurethral resection of bladder tumor or prostate. The intervention consisted of education, local champion(s), and audit-and-feedback of data on the frequency of post-procedural antimicrobial-prescribing.</p><p><strong>Results: </strong>1,272 procedures were performed across all 3 sites at baseline compared to 525 during the intervention period; 644 (50.6%) patients received excess post-procedural antimicrobials during the baseline period compared to 216 (41.1%) during the intervention period. There was no change in the use of post-procedural antimicrobials at sites 1 and 2 between the baseline and intervention periods. At site 3, the odds of prescribing a post-procedural antimicrobial significantly decreased during the intervention period relative to the baseline time trend (0.09; 95% CI 0.02-0.45). There was no significant increase in post-procedural unplanned visits at any of the sites.</p><p><strong>Conclusions: </strong>Implementation of a bundled intervention was associated with reduced post-procedural antimicrobial use at one of three sites, with no increase in complications. These findings demonstrate both the safety and challenge of guideline implementation for optimal perioperative antimicrobial prophylaxis.This trial was registered on clinicaltrials.gov, NCT04196777.</p>","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empiric antibiotic prescribing practices for gram-positive coverage of late-onset sepsis in neonatal intensive care units in North America. 北美新生儿重症监护室对晚期败血症革兰氏阳性病例的经验性抗生素处方。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-07 DOI: 10.1017/ice.2024.176
Dara Simcha Petel, Sandra Isabel, Kyong-Soon Lee, Joseph Yuk Ting, David A Kaufman, Pablo Jose Sanchez, Sarah Khan, Kathryn Timberlake, James Wright, Michelle Science

Late-onset sepsis (LOS) in the neonatal intensive care unit (NICU) causes significant morbidity and mortality, yet guidance on empiric management is limited. We surveyed NICUs across Canada and the United States regarding their empiric antimicrobial regimens for LOS, thereby identifying large practice variations and high rates of empiric vancomycin use.

新生儿重症监护室(NICU)中的晚发败血症(LOS)会导致严重的发病率和死亡率,但有关经验性治疗的指导却很有限。我们对加拿大和美国的新生儿重症监护室进行了调查,了解他们对 LOS 的经验性抗菌药物治疗方案,从而发现了很大的实践差异和万古霉素的高使用率。
{"title":"Empiric antibiotic prescribing practices for gram-positive coverage of late-onset sepsis in neonatal intensive care units in North America.","authors":"Dara Simcha Petel, Sandra Isabel, Kyong-Soon Lee, Joseph Yuk Ting, David A Kaufman, Pablo Jose Sanchez, Sarah Khan, Kathryn Timberlake, James Wright, Michelle Science","doi":"10.1017/ice.2024.176","DOIUrl":"10.1017/ice.2024.176","url":null,"abstract":"<p><p>Late-onset sepsis (LOS) in the neonatal intensive care unit (NICU) causes significant morbidity and mortality, yet guidance on empiric management is limited. We surveyed NICUs across Canada and the United States regarding their empiric antimicrobial regimens for LOS, thereby identifying large practice variations and high rates of empiric vancomycin use.</p>","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What can building information modeling do for you? A perspective on integration into infection prevention and control programs for patient safety. 建筑信息建模能为您做什么?将建筑信息模型融入感染预防和控制计划以确保患者安全的视角。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-05 DOI: 10.1017/ice.2024.179
Scott C Roberts, Trini A Mathew, Windy D Tanner, Richard A Martinello
{"title":"What can building information modeling do for you? A perspective on integration into infection prevention and control programs for patient safety.","authors":"Scott C Roberts, Trini A Mathew, Windy D Tanner, Richard A Martinello","doi":"10.1017/ice.2024.179","DOIUrl":"https://doi.org/10.1017/ice.2024.179","url":null,"abstract":"","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142576125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbial burden on environmental surfaces in long-term care facilities: a quantitative analysis. 长期护理机构环境表面的微生物负担:定量分析。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-31 DOI: 10.1017/ice.2024.129
William A Rutala, Lauren M DiBiase, Amy W Powell, Maria F Gergen, Emily E Sickbert-Bennett, Hajime Kanamori, David J Weber

Background: We conducted a quantitative analysis of the microbial burden and prevalence of epidemiologically important pathogens (EIP) found on long-term care facilities (LTCF) environmental surfaces.

Methods: Microbiological samples were collected using Rodac plates (25cm2/plate) from resident rooms and common areas in five LTCFs. EIP were defined as MRSA, VRE, C. difficile and multidrug-resistant (MDR) Gram-negative rods (GNRs).

Results: Rooms of residents with reported colonization had much greater EIP counts per Rodac (8.32 CFU, 95% CI 8.05, 8.60) than rooms of non-colonized residents (0.78 CFU, 95% CI 0.70, 0.86). Sixty-five percent of the resident rooms and 50% of the common areas were positive for at least one EIP. If a resident was labeled by the facility as colonized with an EIP, we only found that EIP in 30% of the rooms. MRSA was the most common EIP recovered, followed by C. difficile and MDR-GNR.

Discussion: We found frequent environmental contamination with EIP in LTCFs. Colonization status of a resident was a strong predictor of higher levels of EIP being recovered from his/her room.

背景:我们对长期护理设施(LTCF)环境表面的微生物负担和流行病学重要病原体(EIP)进行了量化分析:我们对长期护理设施(LTCF)环境表面的微生物负担和流行病学重要病原体(EIP)的流行率进行了定量分析:使用 Rodac 平板(25 厘米2/平板)从五家长期护理机构的居民房间和公共区域收集微生物样本。EIP定义为MRSA、VRE、艰难梭菌和耐多药(MDR)革兰氏阴性杆菌(GNRs):据报告,定植了菌落的居民房间的每罗达克 EIP 计数(8.32 CFU,95% CI 8.05,8.60)远高于未定植菌落的居民房间(0.78 CFU,95% CI 0.70,0.86)。65%的居民房间和 50%的公共区域至少有一种 EIP 呈阳性。如果某位居民被医疗机构标记为定植了一种 EIP,我们仅在 30% 的房间中发现了该 EIP。MRSA 是最常见的 EIP,其次是艰难梭菌和 MDR-GNR:讨论:我们发现,长者护理中心的环境经常受到 EIP 污染。住户的菌落状态是其房间内 EIP 感染率较高的一个重要预测因素。
{"title":"Microbial burden on environmental surfaces in long-term care facilities: a quantitative analysis.","authors":"William A Rutala, Lauren M DiBiase, Amy W Powell, Maria F Gergen, Emily E Sickbert-Bennett, Hajime Kanamori, David J Weber","doi":"10.1017/ice.2024.129","DOIUrl":"https://doi.org/10.1017/ice.2024.129","url":null,"abstract":"<p><strong>Background: </strong>We conducted a quantitative analysis of the microbial burden and prevalence of epidemiologically important pathogens (EIP) found on long-term care facilities (LTCF) environmental surfaces.</p><p><strong>Methods: </strong>Microbiological samples were collected using Rodac plates (25cm2/plate) from resident rooms and common areas in five LTCFs. EIP were defined as MRSA, VRE, C. difficile and multidrug-resistant (MDR) Gram-negative rods (GNRs).</p><p><strong>Results: </strong>Rooms of residents with reported colonization had much greater EIP counts per Rodac (8.32 CFU, 95% CI 8.05, 8.60) than rooms of non-colonized residents (0.78 CFU, 95% CI 0.70, 0.86). Sixty-five percent of the resident rooms and 50% of the common areas were positive for at least one EIP. If a resident was labeled by the facility as colonized with an EIP, we only found that EIP in 30% of the rooms. MRSA was the most common EIP recovered, followed by C. difficile and MDR-GNR.</p><p><strong>Discussion: </strong>We found frequent environmental contamination with EIP in LTCFs. Colonization status of a resident was a strong predictor of higher levels of EIP being recovered from his/her room.</p>","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifaceted implementation strategy to improve the evaluation of penicillin allergies in perioperative patients: a pre-post feasibility implementation study. 改善围手术期患者青霉素过敏评估的多方面实施策略:一项前后可行性实施研究。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-30 DOI: 10.1017/ice.2024.119
Eileen J Carter, Katherine Zavez, Carol Schramm, Meagan M Zolla, Katelyn Baron, David B Banach

Objective: The U.S. Centers for Disease Control and Prevention encourages nurses to evaluate penicillin allergies as part of hospital-based antibiotic stewardship programs. We evaluated the feasibility of an implementation strategy to improve nurses' comprehensive documentation of penicillin allergies. We defined feasibility as the uptake and acceptability of documentation procedures.

Design: Six-month pre-post feasibility implementation study.

Setting: Outpatient surgical areas of an academic medical center located in the U.S.

Intervention: The implementation strategy was guided by the Capability, Opportunity, Motivation Model for Behavior Change and included, building an interdisciplinary coalition to iteratively evaluate the implementation effort, educational meetings with surgical prescribers and perioperative nurses, the development and distribution of educational pocket cards, and structured communication messages in the electronic medical record.

Results: A total of 426 patients with 487 penicillin allergy records (216 records pre-implementation period, 271 records post-implementation period) were analyzed. Penicillin allergy documentation contained the following information in the pre- versus post-implementation period: symptoms of the reaction (87% vs 87%), timing/years since reaction (8% vs 26%), onset of reaction in relation to taking penicillin (0% vs 21%), how symptoms resolved (0% vs 21%), and penicillin re-exposure (3% vs 21%). Focus groups revealed nurses perceived documentation procedures as highly acceptable. Major drivers of acceptability included the perceived effectiveness of a detailed allergy history and self-efficacy in conducting a detailed allergy history.

Conclusions: Nurses perceived the comprehensive documentation of penicillin allergy history intervention as acceptable, and uptake improved following a theory-informed implementation strategy. We offer implementation strategy components to facilitate nurses' engagement in penicillin allergy evaluation.

目的:美国疾病控制和预防中心鼓励护士评估青霉素过敏症,并将其作为医院抗生素管理计划的一部分。我们评估了改善护士全面记录青霉素过敏的实施策略的可行性。我们将可行性定义为记录程序的接受度和可接受性:设计:为期六个月的实施前-实施后可行性研究:干预措施:干预措施:实施策略以行为改变的能力、机会和动机模型为指导,包括建立跨学科联盟以反复评估实施工作、与手术处方人员和围手术期护士召开教育会议、制作和分发教育口袋卡片以及在电子病历中添加结构化交流信息:共分析了 426 名患者的 487 份青霉素过敏记录(实施前 216 份,实施后 271 份)。实施前与实施后的青霉素过敏记录包含以下信息:反应症状(87% vs 87%)、反应发生的时间/年份(8% vs 26%)、反应发生与服用青霉素的关系(0% vs 21%)、症状如何缓解(0% vs 21%)以及青霉素再次暴露(3% vs 21%)。焦点小组显示,护士们认为记录程序的可接受性很高。可接受性的主要驱动因素包括详细过敏史的感知效果和进行详细过敏史记录的自我效能:结论:护士们认为全面记录青霉素过敏史的干预措施是可接受的,而且在采用理论指导的实施策略后,护士们的接受度有所提高。我们提供了实施策略的组成部分,以促进护士参与青霉素过敏评估。
{"title":"Multifaceted implementation strategy to improve the evaluation of penicillin allergies in perioperative patients: a pre-post feasibility implementation study.","authors":"Eileen J Carter, Katherine Zavez, Carol Schramm, Meagan M Zolla, Katelyn Baron, David B Banach","doi":"10.1017/ice.2024.119","DOIUrl":"https://doi.org/10.1017/ice.2024.119","url":null,"abstract":"<p><strong>Objective: </strong>The U.S. Centers for Disease Control and Prevention encourages nurses to evaluate penicillin allergies as part of hospital-based antibiotic stewardship programs. We evaluated the feasibility of an implementation strategy to improve nurses' comprehensive documentation of penicillin allergies. We defined feasibility as the uptake and acceptability of documentation procedures.</p><p><strong>Design: </strong>Six-month pre-post feasibility implementation study.</p><p><strong>Setting: </strong>Outpatient surgical areas of an academic medical center located in the U.S.</p><p><strong>Intervention: </strong>The implementation strategy was guided by the Capability, Opportunity, Motivation Model for Behavior Change and included, building an interdisciplinary coalition to iteratively evaluate the implementation effort, educational meetings with surgical prescribers and perioperative nurses, the development and distribution of educational pocket cards, and structured communication messages in the electronic medical record.</p><p><strong>Results: </strong>A total of 426 patients with 487 penicillin allergy records (216 records pre-implementation period, 271 records post-implementation period) were analyzed. Penicillin allergy documentation contained the following information in the pre- versus post-implementation period: symptoms of the reaction (87% vs 87%), timing/years since reaction (8% vs 26%), onset of reaction in relation to taking penicillin (0% vs 21%), how symptoms resolved (0% vs 21%), and penicillin re-exposure (3% vs 21%). Focus groups revealed nurses perceived documentation procedures as highly acceptable. Major drivers of acceptability included the perceived effectiveness of a detailed allergy history and self-efficacy in conducting a detailed allergy history.</p><p><strong>Conclusions: </strong>Nurses perceived the comprehensive documentation of penicillin allergy history intervention as acceptable, and uptake improved following a theory-informed implementation strategy. We offer implementation strategy components to facilitate nurses' engagement in penicillin allergy evaluation.</p>","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Operationalizing an adverse event detection surveillance system to support antimicrobial stewardship activities: perceptions and insights from the SHEA research network. 运行不良事件检测监控系统以支持抗菌药物管理活动:SHEA 研究网络的看法和见解。
IF 3 4区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-30 DOI: 10.1017/ice.2024.141
Hawra J Al Lawati, Kimberly L Harvey, Marlena Shin, Hillary Mull, Rebecca P Lamkin, Samuel Golenbock, Dipandita Basnet-Thapa, Judith M Strymish, Matthew Lee, Howard Gold, Matthew Bidwell Goetz, Westyn Branch-Elliman

A surveillance system for measuring patient-level antimicrobial adverse drug events (ADE) may support stewardship activities, however, design and implementation questions remain. In this national survey, stewardship experts favored simple, laboratory-based ADE definitions although there were tensions between feasibility, ability to identify attribution without chart review, and importance of specific ADE.

衡量患者级别抗菌药物不良事件(ADE)的监测系统可为监管活动提供支持,但在设计和实施方面仍存在问题。在这项全国性调查中,尽管在可行性、无需病历审查即可确定归因的能力和特定 ADE 的重要性之间存在矛盾,但监管专家们还是倾向于简单的、基于实验室的 ADE 定义。
{"title":"Operationalizing an adverse event detection surveillance system to support antimicrobial stewardship activities: perceptions and insights from the SHEA research network.","authors":"Hawra J Al Lawati, Kimberly L Harvey, Marlena Shin, Hillary Mull, Rebecca P Lamkin, Samuel Golenbock, Dipandita Basnet-Thapa, Judith M Strymish, Matthew Lee, Howard Gold, Matthew Bidwell Goetz, Westyn Branch-Elliman","doi":"10.1017/ice.2024.141","DOIUrl":"https://doi.org/10.1017/ice.2024.141","url":null,"abstract":"<p><p>A surveillance system for measuring patient-level antimicrobial adverse drug events (ADE) may support stewardship activities, however, design and implementation questions remain. In this national survey, stewardship experts favored simple, laboratory-based ADE definitions although there were tensions between feasibility, ability to identify attribution without chart review, and importance of specific ADE.</p>","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infection Control and Hospital Epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1